Armata Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,085 | $1,159 | $2,169 | $491 |
Gross Profit | 667 | 789 | 1,803 | 114 |
EBITDA | 6,941 | -21,959 | -12,121 | -2,552 |
EBIT | 6,523 | -22,329 | -12,487 | -2,929 |
Net Income | -124,298 | -26,675 | -16,295 | -6,531 |
Net Change In Cash | 1,085 | 1,159 | 2,169 | 491 |
Free Cash Flow | -6,726 | -4,540 | -7,360 | -7,679 |
Cash | 8,688 | 14,756 | 4,328 | 11,688 |
Basic Shares | 36,239 | 36,226 | 36,193 | 36,185 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,904 | $5,174 | $4,529 | $5,508 |
Gross Profit | 3,373 | -29,252 | 3,557 | -29,509 |
EBITDA | -29,691 | -41,111 | -65,447 | -36,054 |
EBIT | -31,222 | -42,436 | -66,419 | -36,946 |
Net Income | -173,799 | -18,916 | -69,045 | -36,917 |
Net Change In Cash | 4,904 | 5,174 | 4,529 | 5,508 |
Cost of Revenue | 9,324 | |||
Free Cash Flow | -26,305 | -39,430 | -55,567 | -34,692 |
Cash | 8,688 | 9,291 | 13,523 | 14,852 |
Basic Shares | 36,239 | 36,160 | 36,076 | 34,294 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.51 |
2025-09-30 | -$0.74 |
2025-06-30 | -$0.45 |
